Public Announcement; Pursuant to The Government in The Sunshine Act (Pub. L. 94-409) [5 U.S.C. Section 552b], 7234 [2011-2670]

Download as PDF 7234 Federal Register / Vol. 76, No. 27 / Wednesday, February 9, 2011 / Notices protocols in effect on May 1, 1971. DEA has investigated Chattem Chemicals, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: February 2, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: February 2, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. consistent with the public interest at this time. DEA has investigated Noramco, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 USC § 823(a), and in accordance with 21 CFR § 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. BILLING CODE 4410–09–P Dated: February 2, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. DEPARTMENT OF JUSTICE [FR Doc. 2011–2826 Filed 2–8–11; 8:45 am] Drug Enforcement Administration BILLING CODE 4410–09–P [FR Doc. 2011–2828 Filed 2–8–11; 8:45 am] [FR Doc. 2011–2829 Filed 2–8–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Registration Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated October 8, 2010, and published in the Federal Register on October 20, 2010, 75 FR 64743, Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Schedule mstockstill on DSKH9S0YB1PROD with NOTICES Phenylacetone (8501) .................. Coca Leaves (9040) ..................... Thebaine (9333) ........................... Opium, raw (9600) ....................... Noroxymorphone (9668) .............. Concentrate of Poppy Straw (9670). II II II II II II The company plans to import the listed controlled substances as raw materials for use in the manufacture of bulk controlled substances for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Johnson Matthey, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Johnson Matthey, Inc. to ensure that the company’s VerDate Mar<15>2010 17:08 Feb 08, 2011 Jkt 223001 By Notice dated October 8, 2010 and published in the Federal Register on October 20, 2010, 75 FR 64745, Noramco, Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801– 4417, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule Codeine-N-oxide (9053) ............... Dihydromorphine (9145) ............... Morphine-N-oxide (9307) ............. Methylphenidate (1724) ................ Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Morphine (9300) ........................... Thebaine (9333) ........................... Opium extracts (9610) .................. Opium fluid extract (9620) ............ Opium tincture (9630) .................. Opium, powdered (9639) ............. Opium, granulated (9640) ............ Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Tapentadol (9780) ........................ I I I II II II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Noramco, Inc. to manufacture the listed basic classes of controlled substances is PO 00000 Frm 00090 Fmt 4703 Sfmt 9990 DEPARTMENT OF JUSTICE United States Parole Commission Public Announcement; Pursuant to The Government in The Sunshine Act (Pub. L. 94–409) [5 U.S.C. Section 552b] Department of Justice, United States Parole Commission. AGENCY HOLDING MEETING: TIME AND DATE: 10 a.m., February 10, 2011. 5550 Friendship Blvd., Fourth Floor, Chevy Chase, MD 20815. PLACE: STATUS: Open MATTERS TO BE CONSIDERED: The following matters have been placed on the agenda for the open Parole Commission meeting: 1. Approval of Minutes for October, November and December 2010 Quarterly Business Meetings. 2. Reports from the Chairman, Commissioners and Section Administrators. Patricia W. Moore, Staff Assistant to the Chairman, United States Parole Commission, (301) 492– 5933. AGENCY CONTACT: Dated: February 1, 2011. Rockne J. Chickinell, General Counsel, U.S. Parole Commission. [FR Doc. 2011–2670 Filed 2–8–11; 8:45 am] BILLING CODE 4410–31–M E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 76, Number 27 (Wednesday, February 9, 2011)]
[Notices]
[Page 7234]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-2670]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

United States Parole Commission


Public Announcement; Pursuant to The Government in The Sunshine 
Act (Pub. L. 94-409) [5 U.S.C. Section 552b]

AGENCY HOLDING MEETING: Department of Justice, United States Parole 
Commission.

TIME AND DATE: 10 a.m., February 10, 2011.

PLACE: 5550 Friendship Blvd., Fourth Floor, Chevy Chase, MD 20815.

STATUS: 

Open

MATTERS TO BE CONSIDERED: The following matters have been placed on the 
agenda for the open Parole Commission meeting:
    1. Approval of Minutes for October, November and December 2010 
Quarterly Business Meetings.
    2. Reports from the Chairman, Commissioners and Section 
Administrators.

AGENCY CONTACT: Patricia W. Moore, Staff Assistant to the Chairman, 
United States Parole Commission, (301) 492-5933.

    Dated: February 1, 2011.
Rockne J. Chickinell,
General Counsel, U.S. Parole Commission.
[FR Doc. 2011-2670 Filed 2-8-11; 8:45 am]
BILLING CODE 4410-31-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.